Retigabine is used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients. It is an anticonvulsant. Reference standards of Retigabine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
N4-[(4-Fluorophenyl)methyl]-2-nitro-1,4-benzenediamine-d4
Catalogue No.:PA STI 041740
CAS :
Molecular Formula : C13H8D4FN3O2
Molecular Weight : 265.28
Retigabine-d4 Dihydrochloride
Catalogue No.:PA STI 077580
Molecular Formula : C16H16D4Cl2FN3O2
Molecular Weight : 380.28
Retigabine-d4 N-β-D-Glucuronide
Catalogue No.:PA STI 077590
Molecular Formula : C22H22D4FN3O8
Molecular Weight : 483.48
Retigabine
Catalogue No.:PA 18 97000
Molecular Formula : C16H18FN3O2
Molecular Weight : 303.34
N-Acetyl Retigabine
Catalogue No.:PA 18 97510
Molecular Formula : C15H16FN3O
Molecular Weight : 273.31
Retigabine Dihydrochloride
Catalogue No.:PA 18 97520
Molecular Formula : C16H20Cl2FN3O2
Molecular Weight : 376.25
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
